Table 3 Summary of dose adjustments during the study period
From: Therapeutic drug monitoring of amikacin in septic patients
Dose administration | ||||||
|---|---|---|---|---|---|---|
24 hrs | 36 hrs | 48 hrs | 72 hrs | |||
Dose management | Increased | 14 | 2 | 4 | 3 | 23 |
Unchanged | 11 | 3 | 2 | - | 16 | |
Decreased | 15 | 2 | 4 | 3 | 24 | |
40 | 7 | 10 | 6 | 63 | ||